{
  "metadata": {
    "source": "FDA Drug Database (Mock)",
    "last_updated": "2025-01-20",
    "record_count": 10
  },
  "drugs": [
    {
      "drug_name": "Metformin",
      "generic_name": "Metformin Hydrochloride",
      "brand_names": ["Glucophage", "Fortamet", "Glumetza"],
      "therapeutic_class": "Antidiabetic",
      "indication": "Type 2 diabetes mellitus",
      "approval_date": "1994-12-28",
      "fda_status": "approved",
      "dosage_forms": ["tablet", "extended-release tablet", "oral solution"],
      "common_dosages": ["500mg", "850mg", "1000mg"],
      "tier_classification": "tier_1_generic",
      "formulary_status": "preferred",
      "prior_auth_required": false,
      "step_therapy_required": false,
      "quantity_limits": "180 tablets per 30 days"
    },
    {
      "drug_name": "Lisinopril",
      "generic_name": "Lisinopril",
      "brand_names": ["Prinivil", "Zestril"],
      "therapeutic_class": "ACE Inhibitor",
      "indication": "Hypertension, heart failure",
      "approval_date": "1987-12-29",
      "fda_status": "approved",
      "dosage_forms": ["tablet"],
      "common_dosages": ["5mg", "10mg", "20mg", "40mg"],
      "tier_classification": "tier_1_generic",
      "formulary_status": "preferred",
      "prior_auth_required": false,
      "step_therapy_required": false,
      "quantity_limits": "30 tablets per 30 days"
    },
    {
      "drug_name": "Atorvastatin",
      "generic_name": "Atorvastatin Calcium",
      "brand_names": ["Lipitor"],
      "therapeutic_class": "HMG-CoA Reductase Inhibitor (Statin)",
      "indication": "Hypercholesterolemia, cardiovascular disease prevention",
      "approval_date": "1996-12-17",
      "fda_status": "approved",
      "dosage_forms": ["tablet"],
      "common_dosages": ["10mg", "20mg", "40mg", "80mg"],
      "tier_classification": "tier_1_generic",
      "formulary_status": "preferred",
      "prior_auth_required": false,
      "step_therapy_required": false,
      "quantity_limits": "30 tablets per 30 days"
    },
    {
      "drug_name": "Ozempic",
      "generic_name": "Semaglutide",
      "brand_names": ["Ozempic", "Wegovy"],
      "therapeutic_class": "GLP-1 Receptor Agonist",
      "indication": "Type 2 diabetes mellitus, weight management",
      "approval_date": "2017-12-05",
      "fda_status": "approved",
      "dosage_forms": ["subcutaneous injection"],
      "common_dosages": ["0.5mg", "1mg", "2mg"],
      "tier_classification": "tier_3_brand",
      "formulary_status": "non-preferred",
      "prior_auth_required": true,
      "step_therapy_required": true,
      "quantity_limits": "1 pen per 28 days",
      "step_therapy_criteria": "Must try metformin and one other oral antidiabetic for 90 days"
    },
    {
      "drug_name": "Eliquis",
      "generic_name": "Apixaban",
      "brand_names": ["Eliquis"],
      "therapeutic_class": "Factor Xa Inhibitor",
      "indication": "Atrial fibrillation, DVT/PE prevention",
      "approval_date": "2012-12-28",
      "fda_status": "approved",
      "dosage_forms": ["tablet"],
      "common_dosages": ["2.5mg", "5mg"],
      "tier_classification": "tier_3_brand",
      "formulary_status": "preferred",
      "prior_auth_required": true,
      "step_therapy_required": false,
      "quantity_limits": "60 tablets per 30 days",
      "prior_auth_criteria": "Documented contraindication to warfarin or INR instability"
    },
    {
      "drug_name": "Levothyroxine",
      "generic_name": "Levothyroxine Sodium",
      "brand_names": ["Synthroid", "Levoxyl", "Unithroid"],
      "therapeutic_class": "Thyroid Hormone",
      "indication": "Hypothyroidism",
      "approval_date": "2002-08-02",
      "fda_status": "approved",
      "dosage_forms": ["tablet", "capsule"],
      "common_dosages": ["25mcg", "50mcg", "75mcg", "100mcg", "125mcg"],
      "tier_classification": "tier_1_generic",
      "formulary_status": "preferred",
      "prior_auth_required": false,
      "step_therapy_required": false,
      "quantity_limits": "30 tablets per 30 days"
    },
    {
      "drug_name": "Albuterol",
      "generic_name": "Albuterol Sulfate",
      "brand_names": ["ProAir", "Ventolin", "Proventil"],
      "therapeutic_class": "Short-Acting Beta Agonist",
      "indication": "Asthma, COPD",
      "approval_date": "1981-04-24",
      "fda_status": "approved",
      "dosage_forms": ["inhaler", "nebulizer solution"],
      "common_dosages": ["90mcg per inhalation", "2.5mg/3mL solution"],
      "tier_classification": "tier_1_generic",
      "formulary_status": "preferred",
      "prior_auth_required": false,
      "step_therapy_required": false,
      "quantity_limits": "2 inhalers per 30 days"
    },
    {
      "drug_name": "Gabapentin",
      "generic_name": "Gabapentin",
      "brand_names": ["Neurontin"],
      "therapeutic_class": "Anticonvulsant",
      "indication": "Neuropathic pain, seizures",
      "approval_date": "1993-12-30",
      "fda_status": "approved",
      "dosage_forms": ["capsule", "tablet", "oral solution"],
      "common_dosages": ["100mg", "300mg", "400mg", "600mg", "800mg"],
      "tier_classification": "tier_1_generic",
      "formulary_status": "preferred",
      "prior_auth_required": false,
      "step_therapy_required": false,
      "quantity_limits": "270 capsules per 30 days"
    },
    {
      "drug_name": "Omeprazole",
      "generic_name": "Omeprazole",
      "brand_names": ["Prilosec"],
      "therapeutic_class": "Proton Pump Inhibitor",
      "indication": "GERD, peptic ulcer disease",
      "approval_date": "1989-09-19",
      "fda_status": "approved",
      "dosage_forms": ["capsule", "tablet"],
      "common_dosages": ["20mg", "40mg"],
      "tier_classification": "tier_1_generic",
      "formulary_status": "preferred",
      "prior_auth_required": false,
      "step_therapy_required": false,
      "quantity_limits": "30 capsules per 30 days"
    },
    {
      "drug_name": "Insulin Glargine",
      "generic_name": "Insulin Glargine",
      "brand_names": ["Lantus", "Basaglar", "Toujeo"],
      "therapeutic_class": "Long-Acting Insulin",
      "indication": "Type 1 and Type 2 diabetes",
      "approval_date": "2000-04-20",
      "fda_status": "approved",
      "dosage_forms": ["subcutaneous injection"],
      "common_dosages": ["100 units/mL", "300 units/mL"],
      "tier_classification": "tier_2_brand",
      "formulary_status": "preferred",
      "prior_auth_required": false,
      "step_therapy_required": false,
      "quantity_limits": "3 vials or pens per 30 days",
      "cost_sharing_cap": "$35 per month (per federal requirement)"
    }
  ]
}
